The New Paper
NTUC secretary-general Ng Chee Meng (far right) visiting the Acumen Research Laboratories yesterday.TNP PHOTOS: JASON QUAH
Dr Ong Siew Hwa, chief executive and chief scientist of Acumen Diagnostics, which has developed a new, more efficient Covid-19 test kit that is now under review by the Health Sciences Authority.
New training initiative will see medical tech firm take on 30 new employees
CLARA CHONG
0 Engagements
The rapid growth of the biotech sector during the pandemic is creating new jobs in the field with medical technology firm Acumen Diagnostics about to add to the headcount.
The company, which opened a Covid-19 clinical lab yesterday, will take on 30 additional employees as part of a new training initiative.
The Straits Times
Medical technology firm will take on 30 staff under new training initiative
Dr Ong Siew Hwa, CEO and chief scientist of Acumen Diagnostics, which opened a Covid-19 clinical lab yesterday and will take on more staff.ST PHOTO: JASON QUAH
https://str.sg/Jjm2
They can read the article in full after signing up for a free account.
Share link:
Or share via:
Sign up or log in to read this article in full
Sign up
All done! This article is now fully available for you
Read now
Get unlimited access to all stories at $0.99/month for the first 3 months.
The Straits Times
Biotech a growing sector in pandemic, with Acumen Diagnostics aiming to hire 30 people under training scheme
Acumen Diagnostics will take on 30 additional staff members as part of a new training initiative.ST PHOTO: JASON QUAH
https://str.sg/JjP6
They can read the article in full after signing up for a free account.
Share link:
Or share via:
Sign up or log in to read this article in full
Sign up
All done! This article is now fully available for you
Read now
Get unlimited access to all stories at $0.99/month for the first 3 months.
Get unlimited access to all stories at $0.99/month for the first 3 months.
Heritas Capital brings out healthcare playbook as it bets on sustained tech adoption
Source: Olga Kononenko/Unsplash Premium
Private equity and venture capital investor Heritas Capital is betting that disruptions caused by the pandemic will have re-shaped behaviour to sustain the digitalisation of healthcare and education systems.
The Singapore-based investment arm of shipping and industrials group IMC Group recently launched its second venture fund (Heritas Venture Fund II) with a target corpus of $30 million to back about a dozen startups in the health tech, edtech, and foodtech sectors.
It is also launching a $150-million private equity growth fund, Heritas Growth Fund III, to invest in businesses that will include later-stage tech companies.